Plain-English translation of NCT07087613 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a digital stethoscope called the Eko CORE 500 to see if it can detect two serious heart conditions: pulmonary hypertension (high blood pressure in the lungs) and reduced ejection fraction (a weakened ability of the heart to pump blood). The device records heart sounds and electrical signals that researchers will analyze using artificial intelligence to look for patterns that match these conditions.
These two heart conditions often go undiagnosed because the standard tests to detect them—like echocardiograms or invasive heart procedures—aren't available everywhere or are time-consuming. If the digital stethoscope can reliably spot these conditions earlier, doctors could start treatment sooner, which could improve outcomes and save lives.
You likely qualify if…
You likely don't qualify if…
You will have a single visit lasting about 20 minutes. A researcher will use the digital stethoscope to record your heart sounds from four standard listening points on your chest while you sit still—each recording takes about 15 seconds. They will also record a three-lead electrical heart signal. The device findings will not be shared with you or added to your medical record; the recordings are only being used to help train and test the artificial intelligence system.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States